<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20160103025817N6</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-04-06</date_registration>
      <primary_sponsor>Kermanshah University of Medical Sciences</primary_sponsor>
      <public_title>The Study of Effectiveness of Mindfulness integrated Cognitive Behavior Therapy on Psychopathology indicators in females with breast cancer</public_title>
      <acronym></acronym>
      <scientific_title>The Study of Effectiveness of Mindfulness integrated Cognitive Behavior Therapy on Psychopathology indicators in females with breast cancer: Randomized controlled trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-02-20</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>30</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/61672</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: random quadratic blocking method-The four blocks of intervention (A) and control (B) groups will be defined (AABB, ABAB, ABBA, BBAA, BABA, BAAB) and numbers 1 to 6 will be written on the cards. The cards are then placed in an envelope. Finally, the cards are randomly selected and a random string is created from the sequence of selected cards.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Condition 1: depression. Condition 2: anxiety.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Cognitive-behavioral therapy integrated with mindfulness is a regular therapeutic approach that integrates mindfulness meditation with the basic components of cognitive and behavioral techniques and will be performed individually on the intervention group for 8 sessions of 60 minutes per week (for two months). The Curriculum for MiCBT Sessions include: Session 1-Introductory presentation about the sessions and rules, an overview of MiCBT, the concept and principles of mindfulness,mindful breathing. Session 2 -Mindful breathing (continued), an overview of a few MiCBT concepts (such as situation, sensory perception, evaluation, body sensations and reaction), the internal causes of intrusive thoughts and their extinction, part-by-part body scanning. Session 3 -Part-by-part body scanning (continued), explaining about body sensations , informal practice. Session 4 -Body scanning exercises (continued), introducing some CBT components in MiCBT (like exposure methods), encountering unpleasant sensations using Subjective Units of Distress Scale(SUDS) (a kind of form that is used for exposure to target events)through bipolar exposure (imaginary exposure to unpleasant situations). Session 5- review of SUDS, Body scanning exercises (continued).Session 6 -Body scanning exercises (continued), interpersonal skills,assertiveness and role-playing. Session 7-Introducing the concepts of compassion and empathy,loving-kindness meditation.Session 8- Review and evaluation. Intervention 2: Control group: The control group will be given psychological training along with a book on breast cancer and will be taught about the course and process of cancer and medication. Training will be individual and in one session.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is Participants are not yet known.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr. AA. parvizifard</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Department of Clinical Psychology, School of Medicine, Razi Blvd.</address>
        <city>Kermanshah</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6715847141</zip>
        <telephone>+98 83 3427 4617</telephone>
        <email>Parvizia@yahoo.com</email>
        <affiliation>Kermanshah University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr. A.A parvizifard</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Department of Clinical Psychology, School of Medicine, Zakaria Azi Blvd.</address>
        <city>Kermanshah</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6715847141</zip>
        <telephone>+98 83 3427 4617</telephone>
        <email>Parvizia@yahoo.com</email>
        <affiliation>Kermanshah University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Being in the age group of 30 to 60 years
Ability to read and write and participate in treatment sessions
More than 6 months have passed since the diagnosis of cancer
Having informed consent to participate in research and completing the informed consent form
Non-development of chronic physical diseases such as diabetes and thyroid disorders
Do not attend psychotherapy sessions for six months before starting treatment
Have no other cancers
No problems with hearing and vision
Non-abuse of drugs
Non-development of severe mental illnesses including schizophrenia, bipolar type 1 disorders and severe personality disorders</inclusion_criteria>
      <agemin>30 years</agemin>
      <agemax>60 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Participate in psychotherapy sessions and other support groups at the same time as the research period</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F33.1</hc_code>
      <hc_code>F06.4</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Major depressive disorder, recurrent, moderate</hc_keyword>
      <hc_keyword>Anxiety disorder due to known physiological condition</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Behavior</i_code>
      <i_code>Behavior</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Cognitive-behavioral therapy integrated with mindfulness is a regular therapeutic approach that integrates mindfulness meditation with the basic components of cognitive and behavioral techniques and will be performed individually on the intervention group for 8 sessions of 60 minutes per week (for two months). The Curriculum for MiCBT Sessions include: Session 1-Introductory presentation about the sessions and rules, an overview of MiCBT, the concept and principles of mindfulness,mindful breathing. Session 2 -Mindful breathing (continued), an overview of a few MiCBT concepts (such as situation, sensory perception, evaluation, body sensations and reaction), the internal causes of intrusive thoughts and their extinction, part-by-part body scanning. Session 3 -Part-by-part body scanning (continued), explaining about body sensations , informal practice. Session 4 -Body scanning exercises (continued), introducing some CBT components in MiCBT (like exposure methods), encountering unpleasant sensations using Subjective Units of Distress Scale(SUDS) (a kind of form that is used for exposure to target events)through bipolar exposure (imaginary exposure to unpleasant situations). Session 5- review of SUDS, Body scanning exercises (continued).Session 6 -Body scanning exercises (continued), interpersonal skills,assertiveness and role-playing. Session 7-Introducing the concepts of compassion and empathy,loving-kindness meditation.Session 8- Review and evaluation.</i_keyword>
      <i_keyword>Control group: The control group will be given psychological training along with a book on breast cancer and will be taught about the course and process of cancer and medication. Training will be individual and in one session.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Depression. Timepoint: Before the intervention, after the end of the intervention and two months after the end of the intervention. Method of measurement: DASS Depression Inventory.</prim_outcome>
      <prim_outcome>Anxiety. Timepoint: Before the intervention, after the end of the intervention and two months after the end of the intervention. Method of measurement: DASS Anxiety Inventory.</prim_outcome>
      <prim_outcome>Stress. Timepoint: Before the intervention, after the end of the intervention and two months after the end of the intervention. Method of measurement: DASS Stress Inventory.</prim_outcome>
      <prim_outcome>Sleep quality. Timepoint: Before the intervention, after the end of the intervention and two months after the end of the intervention. Method of measurement: Pittsburgh Sleep Quality Index.</prim_outcome>
      <prim_outcome>Sexual function. Timepoint: Before the intervention, after the end of the intervention and two months after the end of the intervention. Method of measurement: Rosen Sexual Function Questionnaire.</prim_outcome>
      <prim_outcome>Body image. Timepoint: Before the intervention, after the end of the intervention and two months after the end of the intervention. Method of measurement: Hopwood body image Questionnaire.</prim_outcome>
      <prim_outcome>Demoralization. Timepoint: Before the intervention, after the end of the intervention and two months after the end of the intervention. Method of measurement: kissane demoralization Questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Kermanshah University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-12-12</approval_date>
        <contact_name>Ethics committee of Kermanshah University of Medical Sciences</contact_name>
        <contact_address>Kermanshah, Shahid Beheshti Blvd., Building No. 2, University of Medical Sciences Kermanshah Kermanshah Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
